Probiotics for Irritable Bowel Syndrome

Lactobacillus Plantarum MF 1298 vs Placebo for Irritable Bowel Syndrome.

This randomised, double blind, cross-over study compares the effect (symptoms, fecal bacterial growth, gas production) of three weeks' treatment with lactobacillus plantarum MF 1298 with placebo in patients with irritable bowel syndrome. The results are related to dietary habits, food intolerance and food allergy.

Inclusion Criteria:

• Irritable bowel syndrome according to the Rome II criteria
• regular symptoms

Exclusion Criteria:

• Use of probiotics last three weeks
• pregnancy
• lactation
• co-existing other gastrointestinal disorders
• use of laxatives and antibiotics within last 5 weeks.